Literature DB >> 30977191

T-cell positioning by chemokines in autoimmune skin diseases.

Jillian M Richmond1, James P Strassner1, Kingsley I Essien1, John E Harris1.   

Abstract

Autoimmune skin diseases are complex processes in which autoreactive cells must navigate through the skin tissue to find their targets. Regulatory T cells in the skin help to mitigate autoimmune inflammation and may in fact be responsible for the patchy nature of these conditions. In this review, we will discuss chemokines that are important for global recruitment of T cell populations to the skin during disease, as well as signals that fine-tune their localization and function. We will describe prototypical disease responses and chemokine families that mediate these responses. Lastly, we will include an overview of chemokine-targeting drugs that have been tested as new treatment strategies for autoimmune skin diseases.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; autoimmunity; cell trafficking; chemokines; skin; type 1/type 2/type 17 responses

Mesh:

Substances:

Year:  2019        PMID: 30977191      PMCID: PMC6553463          DOI: 10.1111/imr.12762

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  301 in total

Review 1.  Homing and cellular traffic in lymph nodes.

Authors:  Ulrich H von Andrian; Thorsten R Mempel
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

Review 2.  Regulatory T cells in autoimmune disease.

Authors:  Margarita Dominguez-Villar; David A Hafler
Journal:  Nat Immunol       Date:  2018-06-20       Impact factor: 25.606

3.  Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells.

Authors:  Rei Watanabe; Ahmed Gehad; Chao Yang; Laura L Scott; Jessica E Teague; Christoph Schlapbach; Christopher P Elco; Victor Huang; Tiago R Matos; Thomas S Kupper; Rachael A Clark
Journal:  Sci Transl Med       Date:  2015-03-18       Impact factor: 17.956

4.  Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

Authors:  Stephan Meller; Franziska Winterberg; Michel Gilliet; Anja Müller; Ingrida Lauceviciute; Juliane Rieker; Norbert J Neumann; Robert Kubitza; Michael Gombert; Erich Bünemann; Ulrike Wiesner; Petra Franken-Kunkel; Holger Kanzler; Marie-Caroline Dieu-Nosjean; Ali Amara; Thomas Ruzicka; Percy Lehmann; Albert Zlotnik; Bernhard Homey
Journal:  Arthritis Rheum       Date:  2005-05

5.  Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.

Authors:  Mayte Suárez-Fariñas; Suzanne J Tintle; Avner Shemer; Andrea Chiricozzi; Kristine Nograles; Irma Cardinale; Shenghui Duan; Anne M Bowcock; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2011-04       Impact factor: 10.793

6.  Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.

Authors:  Flavia V Castelino; Jon Seiders; Gretchen Bain; Sarah F Brooks; Christopher D King; James S Swaney; Daniel S Lorrain; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Arthritis Rheum       Date:  2011-05

7.  Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack.

Authors:  Taisuke Ito; Natsuho Ito; Matthias Saatoff; Hideo Hashizume; Hidekazu Fukamizu; Brian J Nickoloff; Masahiro Takigawa; Ralf Paus
Journal:  J Invest Dermatol       Date:  2007-12-27       Impact factor: 8.551

8.  TSLP acts on infiltrating effector T cells to drive allergic skin inflammation.

Authors:  Rui He; Michiko K Oyoshi; Lilit Garibyan; Lalit Kumar; Steven F Ziegler; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

9.  Alopecia areata in aging C3H/HeJ mice.

Authors:  J P Sundberg; W R Cordy; L E King
Journal:  J Invest Dermatol       Date:  1994-06       Impact factor: 8.551

10.  Proton pump inhibitor-induced subacute cutaneous lupus erythematosus.

Authors:  L H Sandholdt; R Laurinaviciene; A Bygum
Journal:  Br J Dermatol       Date:  2014-02       Impact factor: 9.302

View more
  6 in total

Review 1.  Germinal Center-Related G Protein-Coupled Receptors in Antibody-Mediated Autoimmune Skin Diseases: from Basic Research to Clinical Trials.

Authors:  Pengpeng Cao; Ming Yang; Christopher Chang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-08       Impact factor: 8.667

2.  Cross-talk between CXC chemokine ligand 10-CXC chemokine receptor 3 axis and CC chemokine ligand 17-CC chemokine receptor 4 axis in the pathogenesis of oral lichen planus.

Authors:  Nan Tang; Yu-Yao Zhang; Jue-Hua Cheng; Zhi-Bai Zhao; Yuan Fan
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-08-01

3.  Th2 to Th1 Transition Is Required for Induction of Skin Lesions in an Inducible and Recurrent Murine Model of Cutaneous Lupus-Like Inflammation.

Authors:  Nazgol-Sadat Haddadi; Purvi Mande; Tia Y Brodeur; Kaiyuan Hao; Grace E Ryan; Stephanie Moses; Sharon Subramanian; Xhuliana Picari; Khashayar Afshari; Ann Marshak-Rothstein; Jillian M Richmond
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 4.  The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response.

Authors:  Shan He; Jinhua Xu; Jinfeng Wu
Journal:  Oxid Med Cell Longev       Date:  2022-01-19       Impact factor: 6.543

5.  Inflammatory marker trajectories associated with frailty and ageing in a 20-year longitudinal study.

Authors:  Leonard Daniël Samson; Anne-Marie Buisman; José A Ferreira; H Susan J Picavet; W M Monique Verschuren; Annemieke Mh Boots; Peter Engelfriet
Journal:  Clin Transl Immunology       Date:  2022-02-09

Review 6.  Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.

Authors:  Yinghan Wang; Shuli Li; Chunying Li
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-20       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.